News

 

 

Clinical Trials

Marc Ernstoff
Professor
Immunology and Cancer Immunotherapy

  • Bristol Myers Squibb
    A Multi-site, observational, prospective study in US patients with advanced melanoma

J. Marc Pipas
Associate Professor
Molecular Therapeutics

  • Genentech; Roche Laboratories
    STEAM (Sequencing Triplet with Avastin and Maintenance): FOLFOXIRI/Bevacizumab regimens (concurrent and sequential) vs. FOLFOX/Bevacizumab in first-line metastatic colorectal cancer

James Rigas
Associate Professor
Molecular Therapeutics

  • GlaxoSmithKline Group
    A Phase II study of the selective BRAF kinase inhibitor GSK2118436 in subjects with advanced non-small cell lung cancer and BRAF mutations